PRODUODOPA Israel - English - Ministry of Health

produodopa

abbvie biopharmaceuticals ltd, israel - foscarbidopa; foslevodopa - solution for infusion - foslevodopa 240 mg / 1 ml; foscarbidopa 12 mg / 1 ml - treatment of advanced levodopa-responsive parkinson’s disease with severe motor fluctuations and hyperkinesia or dyskinesia when available combinations of parkinson medicinal products have not given satisfactory results.

Produodopa 240 mg/ml + 12 mg/ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

produodopa 240 mg/ml + 12 mg/ml solution for infusion

abbvie limited - foslevodopa; foscarbidopa - solution for infusion - dopa and dopa derivatives

VYALEV SOLUTION Canada - English - Health Canada

vyalev solution

abbvie corporation - foslevodopa; foscarbidopa - solution - 240mg; 12mg - foslevodopa 240mg; foscarbidopa 12mg

VYALEV foslevodopa 2400 mg/10 mL and foscarbidopa 120 mg/10 mL solution for subcutaneous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

vyalev foslevodopa 2400 mg/10 ml and foscarbidopa 120 mg/10 ml solution for subcutaneous infusion vial

abbvie pty ltd - foslevodopa, quantity: 2400 mg; foscarbidopa, quantity: 120 mg - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide - for the treatment of advanced idiopathic parkinson?s disease with severe motor fluctuations despite optimised alternative pharmacological treatment.

Produodopa 2.4g/10ml / 120mg/10ml solution for infusion vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

produodopa 2.4g/10ml / 120mg/10ml solution for infusion vials

abbvie ltd - foscarbidopa; foslevodopa - solution for infusion - 12mg/1ml ; 240mg/1ml

VYALEV combination subcutaneous infusion (ヴィアレブ配合持続皮下注) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

vyalev combination subcutaneous infusion (ヴィアレブ配合持続皮下注)

abbvie gk - foslevodopa; foscarbidopa hydrate - colorless to yellow or brown limpid injection. it may have a reddish or purplish tinge or a slight opalescent light.

Produodopa 240 mg/ml - 12 mg/ml inf. sol. s.c. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

produodopa 240 mg/ml - 12 mg/ml inf. sol. s.c. vial

abbvie sa-nv - foslevodopa 240 mg - eq. levodopa 170 mg; foscarbidopa 12 mg - eq. carbidopa 9 mg - solution for infusion - foslevodopa and decarboxylase inhibitor

Produodopa 240 mg/ml + 12 mg/ml Infusionsvätska, lösning Sweden - English - Läkemedelsverket (Medical Products Agency)

produodopa 240 mg/ml + 12 mg/ml infusionsvätska, lösning

TEVA-LEVOCARBIDOPA TABLET Canada - English - Health Canada

teva-levocarbidopa tablet

teva canada limited - carbidopa; levodopa - tablet - 10mg; 100mg - carbidopa 10mg; levodopa 100mg - dopamine precursors

TEVA-LEVOCARBIDOPA TABLET Canada - English - Health Canada

teva-levocarbidopa tablet

teva canada limited - carbidopa; levodopa - tablet - 25mg; 100mg - carbidopa 25mg; levodopa 100mg - dopamine precursors